MUKKA PROTEINS LTD. share price has zoomed 7% and is presently trading at Rs 52.9.
Meanwhile, the BSE FMCG index is at 22,553.1 .
Among the top gainers in the BSE FMCG index today are AVANTI FEEDS (up 4.9%) and Shree Renuka Sugars (up 4.8%).
Dabur (down 4.2%) and Hindustan Unilever (down 3.0%) are among the top losers today.
Over the last one year, MUKKA PROTEINS LTD. has moved up from Rs 0.0 to Rs 52.9, registering a gain of Rs 52.9 .
On the other hand, the BSE FMCG index has moved up from 18,998.8 to 22,553.1, registering a gain of 18.7% during the last 12 months.
The top gainers among the BSE FMCG index stocks during this same period were Godfrey Phillips (up 155.6%), JYOTHY LABS (up 115.0%) and BOM.BURMAH (up 93.9%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,217.5 (down 0.3%).
The top losers among the BSE Sensex today are Hindustan Unilever (down 3.0%) and Bajaj Finance (down 2.3%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.
In the meantime, NSE Nifty is at 24,409.1 (down 0.3%). Hindustan Unilever and Tata Consumer Products are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,217.5, registering a gain of 13,832.7 points (up 20.8%).
MUKKA PROTEINS LTD. net profit fell {profitpercent} YoY to Rs 277 million for the quarter ended March 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 2,567 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2023, MUKKA PROTEINS LTD. reported 84.1% increase in net profit to Rs 475 million compared to net profit of Rs 258 million during FY22. Revenue of the company grew 52.8% to Rs 11,771 million during FY23.
Equitymaster requests your view! Post a comment on "MUKKA PROTEINS LTD. Gains 7%; BSE FMCG Index Up 0.0%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!